findmyKOL
Clinical trialNCT02591420CompletedPhase 1Interventional

Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment24HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the safety and virologic effect of an experimental human monoclonal antibody (mAb), VRC-HIVMAB060-00-AB (VRC01), alone or in combination with antiretroviral therapy (ART), in adults during early acute HIV infection.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • LTC Julie Ake, MD

    U.S. Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)

    Study Chair
  • Merlin Robb, MD

    US Military HIV Research Program

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Kenya
  • Kenya Med. Research Inst./walter Reed Project, Clinical Research Centre, Off Hospital Road. Kericho

    Kericho, Kenya

Tanzania
  • National Institute for Medical Research (nimr)-Mbeya Medical Research Center (mmrc) Non-Network Crs

    Mbeya, Tanzania

Thailand
  • Search Thai Red Cross Aids Research Centre Non-Network Crs

    Bangkok, Thailand

  • Echo Center Non-Network Crs

    Chon Buri, Thailand

Uganda
  • Makerere University Walter Reed Project (muwrp)

    Kampala, Uganda

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Antiretroviral therapyPlacebo for VRC01VRC01
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2016
Primary completion
15 Mar 2021
Completion
15 Mar 2021
Last update posted
23 Jul 2026
Registered enrollment
24
Registry id
NCT02591420

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.